Financials Beauty Farm Medical and Health Industry Inc.

Equities

Market Closed - Hong Kong S.E. Other stock markets 01:38:03 11/07/2025 pm IST			5-day change	1st Jan Change
29.80 ^HKD	+4.93%		+2.94%	+67.42%

11/07	Beauty Farm Medical Buys Back Shares From Open Market; Shares Gain 3%	MT
10/07	Beauty Farm Medical and Health Industry Inc. announces an Equity Buyback for 23,579,556 shares, representing 10% of its issued share capital.	CI

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027
Net sales ¹	-	1,635	2,145	2,572	3,024	3,330	3,668
Change	-	-	31.16%	19.9%	17.56%	10.13%	10.15%
EBITDA ¹	-	443.1	616.2	695.2	708.9	792.6	915.3
Change	-	-	39.07%	12.83%	1.97%	11.81%	15.48%
EBIT ¹	-	152.1	291.3	321.8	404.7	471.2	546.1
Change	-	-	91.52%	10.48%	25.75%	16.43%	15.91%
Interest Paid ¹	-	-21.62	-24.81	-3.941	-23.44	-29.94	-35.33
Earnings before Tax (EBT) ¹	-	130.5	288.3	317.9	406.2	476.7	553.4
Change	-	-	120.94%	10.27%	27.77%	17.37%	16.1%
Net income ¹	193.5	103.1	215.7	228.5	291.8	344.6	403.7
Change	-	-46.71%	109.15%	5.94%	27.71%	18.1%	17.17%
Announcement Date	29/12/22	29/03/23	26/03/24	26/03/25	-	-	-

¹CNY in Million

Estimates

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027
Net Debt ¹	-	242	339	274	10.5	-286	-631
Change	-	-	40.08%	-19.17%	-96.17%	-2,823.81%	-120.63%
Announcement Date	29/12/22	29/03/23	26/03/24	26/03/25	-	-	-

¹CNY in Million

Estimates

Fiscal Period: December	2022	2023	2024	2025	2026	2027
CAPEX ¹	140.8	159.2	114.2	207.1	199.9	360.5
Change	-	13.1%	-28.29%	81.41%	-3.49%	80.34%
Free Cash Flow (FCF) ¹	-	466.3	-	-	-	-
Change	-	-	-	-	-	-
Announcement Date	29/03/23	26/03/24	26/03/25	-	-	-

¹CNY in Million

Estimates

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027
Profitability
EBITDA Margin (%)	-	27.09%	28.72%	27.03%	23.44%	23.8%	24.95%
EBIT Margin (%)	-	9.3%	13.58%	12.51%	13.38%	14.15%	14.89%
EBT Margin (%)	-	7.98%	13.44%	12.36%	13.43%	14.31%	15.09%
Net margin (%)	-	6.3%	10.05%	8.88%	9.65%	10.35%	11.01%
FCF margin (%)	-	-	21.74%	-	-	-	-
FCF / Net Income (%)	-	-	216.21%	-	-	-	-
Profitability
ROA	-	3.16%	7.44%	6.03%	7.84%	8.34%	8.41%
ROE	-	46.23%	43.54%	26.16%	30.06%	30.78%	29.69%
Financial Health
Leverage (Debt/EBITDA)	-	0.55x	0.55x	0.39x	0.01x	-	-
Debt / Free cash flow	-	-	0.73x	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	-	8.61%	7.42%	4.44%	6.85%	6%	9.83%
CAPEX / EBITDA (%)	-	31.78%	25.84%	16.43%	29.22%	25.22%	39.39%
CAPEX / FCF (%)	-	-	34.15%	-	-	-	-
Items per share
Cash flow per share ¹	-	1.909	2.719	3.467	2.87	3.4	4.24
Change	-	-	42.39%	27.54%	-17.23%	18.47%	24.71%
Dividend per Share ¹	-	0.34	0.43	0.52	0.61	0.7	-
Change	-	-	26.47%	20.93%	17.31%	14.75%	-
Book Value Per Share ¹	-	1.831	3.401	4.006	4.378	5.345	6.603
Change	-	-	85.75%	17.8%	9.27%	22.1%	23.54%
EPS ¹	1.94	0.52	0.94	0.99	1.245	1.47	1.723
Change	-	-73.2%	80.77%	5.32%	25.76%	18.07%	17.23%
Nbr of stocks (in thousands)	-	-	2,35,796	2,35,796	2,35,735	2,35,735	2,35,735
Announcement Date	29/12/22	29/03/23	26/03/24	26/03/25	-	-	-